Description
This test detects total antibodies (IgG, IgM, and IgA) directed against the SARS-CoV-2 spike (S) protein. It is used to evaluate immune response following prior infection or vaccination.
Clinical Use
- Assessment of prior COVID-19 exposure
- Evaluation of immune response following vaccination
- Documentation of serologic response
- Immune status evaluation in higher-risk individuals
Methodology
Immunoassay Qualitative detection of total antibodies to SARS-CoV-2 spike protein
Specimen Type
Serum (blood draw)
